🔗 Permalink

Assignee profile:

SCHABAR RESEARCH ASSOCIATES LLC

City:

Jupiter, Florida

Country:

United States

Published Applications:

Last publication date:

2022-10-20

Patent Grants:

Last grant date:

2026-01-06

Top Inventors for applications by SCHABAR RESEARCH ASSOCIATES LLC

These are the the leading inventors for applications assigned to SCHABAR RESEARCH ASSOCIATES LLC:

Bernard Schachtel 6 Jupiter, FL United States
Bernard P Schachtel 5 Jupiter, FL United States

Recent patent applications by SCHABAR RESEARCH ASSOCIATES LLC

SCHABAR RESEARCH ASSOCIATES LLC based in Jupiter, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-10-20 ✅ Patent 12,514,846 granted on 2026-01-06

US20220331295A1

Human necessities

UNIT ORAL DOSE COMPOSITIONS COMPOSED OF IBUPROFEN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND FAMOTIDINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR THE TREATMENT OF ACUTE PAIN AND THE REDUCTION OF THE SEVERITY AND/OR RISK OF HEARTBURN AND/OR UPSET STOMACH

#2 | 2022-07-28 ✅ Patent 12,053,457 granted on 2024-08-06

US20220233510A1

Human necessities

Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn

#3 | 2022-07-28 ✅ Patent 12,048,690 granted on 2024-07-30

US20220233509A1

Human necessities

Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn

#4 | 2022-01-20 ✅ Patent 11,331,307 granted on 2022-05-17

US20220016088A1

Human necessities

Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn

#5 | 2022-01-20 ✅ Patent 11,324,727 granted on 2022-05-10

US20220016087A1

Human necessities

Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn

#6 | 2018-10-25

US20180303801A1

Human necessities

UNIT ORAL SOLID DOSE COMPOSITIONS COMPOSED OF IBUPROFEN AND NIZATIDINE

#7 | 2017-04-06

US20170095455A1

Human necessities

UNIT ORAL SOLID DOSE COMPOSITIONS COMPOSED OF NAPROXEN SODIUM AND NIZATIDINE

#8 | 2015-10-01

US20150272933A1

Human necessities

UNIT ORAL SOLID DOSE COMPOSITIONS COMPOSED OF A PHARMACEUTICALLY ACCEPTABLE SALT OF NAPROXEN AND NIZATIDINE OR THE PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

#9 | 2015-10-01

US20150272932A1

Human necessities

USE OF ANALGESIC POTENTIATING COMPOUNDS TO POTENTIATE THE ANALGESIC PROPERTIES OF AN ANALGESIC COMPOUND

#10 | 2014-09-18 ✅ Patent 9,044,465 granted on 2015-06-02

US20140275188A1

Human necessities

Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound

#11 | 2011-01-20 ✅ Patent 8,771,643 granted on 2014-07-08

US20110014127A1

Human necessities

Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound

Also check out SCHABAR RESEARCH ASSOCIATES LLC's (Jupiter, United States) applicant profile with 6 patent applications submitted.

AssigneeID:

99247 ⎘